In-vivo impaired T helper 1 cell development in submandibular lymph nodes due to IL-12 deficiency following antigen injection into the anterior chamber of the eye

Ocular Immunology and Inflammation

Volumn 8, Issue 1, 2000, Pages 9-24

  Perez, Victor L ^a   Biuckians, Andre ^a   Streilein, J Wayne ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Antigen presentation; Cytokines; In vivo animal model; Lymph node; Th1 Th2

Indexed keywords

ANTIGEN; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR EYE CHAMBER; ANTIGEN SPECIFICITY; ARTICLE; CELL CYCLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOPHENOTYPING; LYMPH NODE; LYMPHATIC DRAINAGE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN DEFICIENCY; SUBMANDIBULAR GLAND; T LYMPHOCYTE; TH1 CELL;

EID: 0033864086     PISSN: 09273948     EISSN: None     Source Type: Journal    
DOI: 10.1076/0927-3948(200003)8:1;1-s;ft009     Document Type: Article

References (30)

1. Streilein JW. Tissue barriers, immunosuppressive microenvironments, and privileged sites: the eye's point of view. Reg Immunol 1993;5:253-268.
2. Streilein JW, Ksander BR, Taylor AW. Immune deviation in relation to ocular immune privilege. J Immunol 1997;158:3557-3560.
3. Streilein JW. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr Opin Immunol 1993;5:428-432.
4. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligandinduced apoptosis as a mechanism of immune privilege. Science 1995;270:1189-1192.
5. Streilein JW, Niederkom JY. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med 1981;153:1058-1067.
6. Wilbanks GA, Streilein JW. Studies on the induction of anterior chamber associated immune deviation (ACAID). Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J Immunol 1991;146:2610-2617.
7. Tripathi RC, Tripathi BJ. Functional anatomy of the anterior chamber angle. In: Jakobiec FA, editor. Ocular Anatomy, Embryology and Teratology. Philadelphia: Harper and Row, 1982;197-284.
8. Tripathi RC. Uveoscleral drainage of aqueous humor. Exp Eye Res 1977; Suppl.:305-308.
9. Egan RM, Yorkey C, Black R, Loh WK, Stevens JL, Woodward JG. Peptide-specific T cell clonal expansion in vivo following immunization in the eye, an immuneprivileged site. J Immunol 1996;157:2262-2271.
10. Bando Y, Ksander BR, Streilein JW. Incomplete activation of lymphokine-producing T cells by alloantigenic intraocular tumors in anterior chamber-associated immune deviation. Immunology 1993;78:266-272.
11. Kearney ER, Pape KA, Loh DY, Jenkins MK. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1995;1:327-339.
12. low thymocytes in vivo. Science 1990;250:1720-1723.
13. Perez VL, Van Parijs L, Biuckians A, Zheng XX, Strom TB, Abbas AK. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 1997;6:411-417.
14. Kosiewicz MM, Okamoto S, Miki S, Ksander BR, Shimizu T, Streilein JW. Imposing deviant immunity on the presensitized state. J Immunol 1994;153:2962-2973.
15. Haskins K, Kubo R, White J, Pigeon M, Kappler J, Marrack P. The MHC-restricted antigen receptor on T cells. I. Isolation of a monoclonal antibody. J Exp Med 1983;157:1149-1169.
16. Kearney ER, Walunas TL, Karr RW, Morton PA, Loh DY, Bluestone JA, Jenkins MK. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4 T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J Immunol 1995;155:1032-1036.
17. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383:787-793.
18. McKnight AJ, Zimmer GJ, Fogelman I, Wolf SF, Abbas AK. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J Immunol 1994;152:2172-2179.
19. Cousins SW, Trattler WB, Streilein JW. Immune privilege and suppression of immunogenic inflammation in the anterior chamber of the eye. Curr Eye Res 1991;10:287-297.
20. Medawar P. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 1948;29:58-69.
21. Linssen A, Rothova A, Valkenburg HA, Dekker SA, Luyendijk L, Kijlstra A, Feltkamp T. The lifetime cumulative incidence of acute anterior uveitis in a normal population of and its relation to ankylosing spondylitits and histocompatibility antigen HLA-B27. Invest Ophthalmol Vis Sci 1991;32:2568-2578.
22. Caspi RR, Roberge FG, Chan CC, Wiggert B, Chader GJ, Rozenszajn LA, Lando Z, Nussenblatt RB. A new model of autoimmune disease: experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol 1988;149:1490-1495.
23. Streilein JW, Dana MR, Ksander BR. Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol Today 1997;18:443-449.
24. Wilbanks GA, Streilein JW. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-B. Eur J Immunol 1992;22:1031-1036.
25. Takeuchi M, Alard P, Streilein JW. TGFβ promotes immune deviation by altering accessory signals of antigen presenting cells. J Immunol 1998;160(4):1589-1597.
26. Kosiewicz MM, Streilein JW. Intraocular injection of class II-restricted peptide induces an unexpected population of CDS regulatory cells. J Immunol 1996;157(5):1905-1912.
27. Wang Y, Goldschneider I, Foss D, Wu DY, O'Rourke J, Cone RE. Direct thymic involvement in anterior-chamber associated immune deviation: evidence for a nondeletional mechanism of centrally induced tolerance to extrathymic antigens in adults mice. J Immunol 1997;158(5):2150-2155.
28. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigenspecific adaptive immunity (Review). Annu Rev Immunol 1995;13:251-276.
29. Windhagen A, Newcombe J, Dangond F, Strand C, Woodroofe MN, Cuzner ML, Hafler DA. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med 1995;182:1985-1996.
30. Trembleau S, Germann T, Gately MK, Adorini L. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol Today 1995;16:383-386.